Skip to content
Vaskapu u. 10-14. B.ép. III/10. | 1097 Budapest (HUNGARY)
+36 (30) 977 6092
info@laboratorystandards.eu
Home
Product categories
Documents
Research Chemicals for Life Science and Drug Discovery
Catalogue
Pipettes
Liquid handling
PURA Water Baths
Laboratory Supplies
Karl Fischer Reagents and Standards
Phospholipids & Fatty Acids
Stable Isotope Labeled Compounds, NMR Tubes
Contact
Privacy Policy
Menu
Home
Product categories
Documents
Research Chemicals for Life Science and Drug Discovery
Catalogue
Pipettes
Liquid handling
PURA Water Baths
Laboratory Supplies
Karl Fischer Reagents and Standards
Phospholipids & Fatty Acids
Stable Isotope Labeled Compounds, NMR Tubes
Contact
Privacy Policy
Search
Code
Description
Unit
USP-1448978
Mycophenolate Mofetil Related Compound B - [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one]
15 mg
USP-1448967
Mycophenolate Mofetil Related Compound A - 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
15 mg
USP-1448956
Mycophenolate Mofetil
200 mg
USP-1448923
Mupirocin Lithium
100 mg
USP-1448912
Mupirocin Calcium
200 mg
USP-1448901
Mupirocin
50 mg
USP-1448617
Moxifloxacin Related Compound A - 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
25 mg
USP-1448606
Moxifloxacin Hydrochloride (HCl)
200 mg
USP-1448560
Moxidectin System Suitability Mixture
50 mg
USP-1448027
Morphine Sulfate Related Compound B - Pseudomorphine CII (controlled substance in USA)
20 mg